Probiotics in the Management of Crohn's disease and Ulcerative Colitis

被引:11
作者
Muellner, Katalin [1 ]
Miheller, Pal [1 ]
Herszenyi, Laszlo [1 ]
Tulassay, Zsolt [1 ]
机构
[1] Semmelweis Univ, Dept Internal Med 2, H-1088 Budapest, Hungary
关键词
Probiotics; inflammatory bowel disease; ESCHERICHIA-COLI; MAINTAINING REMISSION; LACTOBACILLUS GG; DOUBLE-BLIND; IN-VITRO; MAINTENANCE; THERAPY; PATHOGENESIS; PLACEBO; INEFFECTIVENESS;
D O I
10.2174/13816128113196660727
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Probiotics are nowadays frequently used by patients with inflammatory bowel disease, however literature data are conflicting related to their importance. In mild to moderate ulcerative colitis probiotics can be used effectively in induction and maintaining remission, and prevention of pouchitis. As the other side of the shield, there is not sufficient evidence to support the use of probiotics in daily clinical practice in Crohn's disease. The aim of the present review is to provide help for clinicians about the probiotic use in patients with inflammatory bowel disease. The comparison of literature data is limited by the large number of probiotic strains, various combined preparations, and different doses applied in the clinical studies. Small number of comparable protocols and lack of standardization encumber the analysis of study results.
引用
收藏
页码:4556 / 4560
页数:5
相关论文
共 43 条
[1]   Review article: the evidence base for interventions used to maintain remission in Crohn's disease [J].
Akobeng, A. K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (01) :11-18
[2]   European evidence-based Consensus on the management of ulcerative colitis: Special situations (Publication with Expression of Concern) [J].
Biancone, Livia ;
Michetti, Pierre ;
Travis, Simon ;
Escher, Johanna C. ;
Moser, Gabriele ;
Forbes, Alastair ;
Hoffmann, Joerg C. ;
Dignass, Axel ;
Gionchetti, Paolo ;
Jantschek, Guenter ;
Kiesslich, Ralf ;
Kolacek, Sanja ;
Mitchell, Rod ;
Panes, Julian ;
Soderholm, Johan ;
Vucelic, Boris ;
Stange, Eduard .
JOURNAL OF CROHNS & COLITIS, 2008, 2 (01) :63-92
[3]   A randomized, double-blind trial of lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease [J].
Bousvaros, A ;
Guandalini, S ;
Baldassano, RN ;
Botelho, C ;
Evans, J ;
Ferry, GD ;
Goldin, B ;
Hartigan, L ;
Kugathasan, S ;
Levy, J ;
Murray, KE ;
Oliva-Hemker, M ;
Rosh, JR ;
Tolia, V ;
Zholudev, A ;
Vanderhoof, JA ;
Hibberd, PL .
INFLAMMATORY BOWEL DISEASES, 2005, 11 (09) :833-839
[4]   Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative? [J].
Campieri, M ;
Gionchetti, P .
GASTROENTEROLOGY, 1999, 116 (05) :1246-1249
[5]  
Ciorba MA, CLIN GASTROENTEROL H
[6]   Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus [J].
Collado, M. C. ;
Meriluoto, J. ;
Salminen, S. .
LETTERS IN APPLIED MICROBIOLOGY, 2007, 45 (04) :454-460
[7]   Probiotics in the treatment of human inflammatory bowel diseases - Update 2008 [J].
Fedorak, Richard Neil ;
Dieleman, Levinus Albert .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (06) :S97-S103
[8]   Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system [J].
Ghadimi, Darab ;
Helwig, Ulf ;
Schrezenmeir, Juergen ;
Heller, Knut J. ;
de Vrese, Michael .
JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 92 (04) :895-911
[9]   Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial [J].
Gionchetti, P ;
Rizzello, F ;
Helwig, U ;
Venturi, A ;
Lammers, KM ;
Brigidi, P ;
Vitali, B ;
Poggioli, G ;
Miglioli, M ;
Campieri, M .
GASTROENTEROLOGY, 2003, 124 (05) :1202-1209
[10]   High-dose probiotics for the treatment of active pouchitis [J].
Gionchetti, Paolo ;
Rizzello, Fernando ;
Morselli, Claudia ;
Poggioli, Gilberto ;
Tambasco, Rosi ;
Calabrese, Carlo ;
Brigidi, Patrizia ;
Vitali, Beatrice ;
Straforini, Giulia ;
Campieri, Massimo .
DISEASES OF THE COLON & RECTUM, 2007, 50 (12) :2075-2082